Do you think there's a risk that a group predominantly made up of big multinationals will prioritize access to innovative drugs over domestic manufacturing capacity?
Maxime Blanchette-Joncas Bloc Rimouski—La Matapédia, QC
Do you think there's a risk that a group predominantly made up of big multinationals will prioritize access to innovative drugs over domestic manufacturing capacity?
See context to find out what was said next.